4/A
Changes in Ownership
Caribou Biosciences, Inc. Filed Acc 0001209191-22-028169
President and CEO acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Haurwitz Rachel E. President and CEO | 2022-01-26 | Option exercise | +10,000 | $2.96 | $29,600 | 10,000 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Haurwitz Rachel E. President and CEO | 2022-01-26 | Option exercise · Option to purchase Common Stock | −10,000 | 126,350 | D: show line 2 in the form |
Loading xslF345X03/doc4a.xml…